Fed. Circ. Told Minerva Still Can't Challenge Hologic Patent
Surgical device company Minerva shouldn't be able to strike down Hologic's patent covering an endometrial treatment despite a recent U.S. Supreme Court decision limiting when inventors are barred from challenging their...To view the full article, register now.
Already a subscriber? Click here to view full article